ENANTA PHARMACEUTICALS INC (ENTA) Net margin 2017–2025
ENANTA PHARMACEUTICALS INC (ENTA) net profit margin by fiscal year — reported net income divided by reported revenue.
-177.6%FY2025 · since FY2017: 21.1% → -177.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -177.6% | +20.2 pp |
| FY2024 | -197.9% | -44.1 pp |
| FY2023 | -153.7% | -62.0 pp |
| FY2022 | -91.7% | -54.4 pp |
| FY2021 | -37.3% | -75.1 pp |
| FY2020 | 37.9% | +2.8 pp |
| FY2019 | 35.1% | +26.5 pp |
| FY2018 | 8.6% | -12.5 pp |
| FY2017 | 21.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice